SHFL
ABBV icon

Seven Hills Financial, LLC’s AbbVie ABBV Stock Holding History

Seven Hills Financial, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$361K Buy
+1,381
New +$354K 0.22% 64

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Seven Hills Financial, LLC's ABBV Position: Q3 2026 in Review

Seven Hills Financial, LLC opened a new position in AbbVie (ABBV) in Q3 2026: 1,381 shares worth $361K. The stake represents 0.22% of the portfolio and ranks #64 among its holdings.

374 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Seven Hills Financial, LLC held 1,381 shares of AbbVie worth $361K as of Q3 2026.
  • AbbVie was a new Seven Hills Financial, LLC position in Q3 2026.
  • AbbVie made up 0.22% of Seven Hills Financial, LLC's portfolio in Q3 2026, its #64 holding.
  • 374 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Seven Hills Financial, LLC's 13F filing for Q3 2026, filed 13 Oct 2026.